# A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome

> **NCT05946941** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Bristol-Myers Squibb** · enrollment: 774 (actual)

## Conditions studied

- Sjögren's Syndrome

## Interventions

- **DRUG:** Deucravacitinib
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05946941
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-09-11
- **Primary completion:** 2026-11-18
- **Final completion:** 2028-11-16
- **Target enrollment:** 774 (ACTUAL)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05946941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05946941, "A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05946941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*